Provided by Tiger Fintech (Singapore) Pte. Ltd.

Clearmind Medicine, Inc.

0.9000
+0.01101.24%
Post-market: 0.8703-0.0297-3.30%19:55 EDT
Volume:100.39K
Turnover:91.43K
Market Cap:4.62M
PE:-0.80
High:0.9100
Open:0.9000
Low:0.8715
Close:0.8890
Loading ...

Clearmind Medicine Inc. Doses First Participant in Groundbreaking Clinical Trial for Alcohol Use Disorder Treatment

Reuters
·
11 hours ago

Clearmind Medicine announces first participant ever dosed with CMND-100

TIPRANKS
·
Yesterday

Clearmind Medicine Announces First Participant Ever Dosed With Its Cmnd-100 Treatment in Groundbreaking Clinical Trial for Alcohol Use Disorder

THOMSON REUTERS
·
Yesterday

Clearmind Adds New Site to Trial for Experimental Alcohol Use Disorder Drug

MT Newswires Live
·
27 Jun

Clearmind Medicine expands global clinical trial targeting AUD market

TIPRANKS
·
27 Jun

Clearmind Medicine Expands Global Clinical Trial Targeting Multibillion-Dollar Alcohol Use Disorder Market

THOMSON REUTERS
·
27 Jun

BRIEF-Clearmind Medicine Enrolls First Patient in its Clinical Trial for Alcoholism Treatment

Reuters
·
25 Jun

Clearmind Medicine Enrolls First Patient in Its Clinical Trial for Alcoholism Treatment

THOMSON REUTERS
·
25 Jun

Clearmind Medicine Expands Alcohol Use Disorder Clinical Trial with Addition of Tel Aviv Sourasky Medical Center

Reuters
·
23 Jun

Clearmind Medicine Enrolls First Patient in Study of Potential Alcohol Abuse Treatment

MT Newswires Live
·
05 Jun

Clearmind Medicine Announces Enrollment of First Patient in Phase I/Iia Clinical Trial for Alcohol Use Disorder Treatment

THOMSON REUTERS
·
05 Jun

Psychedelic: Clearmind completes clinical site initiations for AUD trial

TipRanks
·
25 Apr

SciSparc-Clearmind Collaboration Leads to Filing of International Patent Application for Novel Treatment of Anorexia, Bulimia and other Eating Disorders

GlobeNewswire
·
25 Apr

Clearmind Medicine Files International Patent Application for Novel Treatment of Anorexia, Bulimia and other Eating Disorders

GlobeNewswire
·
25 Apr

BRIEF-Clearmind Medicine Completes The Initiation Of Its Alcohol Use Disorder Phase I/IIA Clinical Trial At All Current Clinical Sites

Reuters
·
23 Apr

Clearmind Medicine Completes the Initiation of Its Alcohol Use Disorder Phase I/Iia Clinical Trial at All Current Clinical Sites

THOMSON REUTERS
·
23 Apr

Clearmind Medicine Completes the Initiation of its Alcohol Use Disorder Phase I/IIa Clinical Trial at all Current Clinical Sites

GlobeNewswire
·
23 Apr

Clearmind Medicine to Host Live Webinar “Gazing Through the Crystal Ball” Featuring Leading Psychedelic Experts

GlobeNewswire
·
21 Apr

BRIEF-Clearmind Medicine Receives Notice Of Allowance For United States Patent Covering Binge Behavior

Reuters
·
17 Apr

Clearmind Medicine Receives Notice of Allowance for United States Patent Covering Binge Behavior

THOMSON REUTERS
·
17 Apr